Signaling pathways involved in isoprostane-mediated fibrogenic effects in rat hepatic stellate cells

Free Radical Biology and Medicine

Volumn 65, Issue , 2013, Pages 201-207

  Acquaviva, Alessandra ^a   Vecchio, Daniela ^a   Arezzini, Beatrice ^a   Comporti, Mario ^a   Gardi, Concetta ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

15 F2t IsoP; cAMP; Collagen synthesis; Free radicals; Isoprostane receptor; Liver fibrosis; MAPK

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLIC AMP; CYCLIN D1; G PROTEIN COUPLED RECEPTOR; INOSITOL TRISPHOSPHATE; ISOPROSTANE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C JUN; 15-F2T-ISOPROSTANE; THROMBOXANE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FIBROGENESIS; ISOLATED LIVER; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STELLATE CELL; WESTERN BLOTTING; ANIMAL; CELL CULTURE; LIVER CIRRHOSIS; METABOLISM; PHYSIOLOGY;

RATTUS;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; HEPATIC STELLATE CELLS; ISOPROSTANES; LIVER CIRRHOSIS; RATS; RECEPTORS, THROMBOXANE; SIGNAL TRANSDUCTION;

EID: 84881289773     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.06.023     Document Type: Article

References (64)

1. S.L. Friedman Liver fibrosis - from bench to bedside J. Hepatol. 38 2003 38 53
2. R. Bataller, and D.A. Brenner Liver fibrosis J. Clin. Invest. 115 2005 209 231
3. S.L. Friedman Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver Physiol. Rev. 88 2008 125 172
4. L. Atzori, G. Poli, and A. Perra Hepatic stellate cell: a star cell in the liver Int. J. Biochem. Cell. Biol. 41 2009 1639 1642
5. S.J. Forbes, and M. Parola Liver fibrogenic cells Best Pract. Res. Clin. Gastroenterol 25 2011 207 217
6. T. Kisseleva, H. Uchinami, N. Feirt, O. Quintana-Bustamante, J.C. Segovia, R.F. Schwabe, and D.A. Brenner Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis J. Hepatol. 45 2006 429 438
7. D. Cassiman, L. Libbrecht, V. Desmet, C. Denef, and T. Roskams Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers J. Hepatol. 36 2002 200 209
8. M. Comporti, C. Signorini, S. Leoncini, C. Gardi, L. Ciccoli, A. Giardini, D. Vecchio, and B. Arezzini Ethanol-induced oxidative stress: basic knowledge Genes Nutr. 5 2010 101 109
9. V. Sánchez-Valle, N.C. Chávez-Tapia, M. Uribe, and N. Méndez-Sánchez Role of oxidative stress and molecular changes in liver fibrosis: a review Curr. Med. Chem. 19 2012 4850 4860
10. H.L. Ha, H.J. Shin, M.A. Feitelson, and D.Y. Yu Oxidative stress and antioxidants in hepatic pathogenesis World J. Gastroenterol. 16 2010 6035 6043
11. D.F. Taber, J.D. Morrow, and L.J. Roberts 2nd A nomenclature system for isoprostanes Prostaglandins 53 2010 63 67
12. P. Montuschi, P. Barnes, and L.J. Roberts 2nd Insights into oxidative stress: the isoprostanes Curr. Med. Chem. 14 2007 703 717
13. M. Comporti, C. Signorini, B. Arezzini, D. Vecchio, B. Monaco, and C. Gardi Isoprostanes and hepatic fibrosis Mol. Aspects Med. 29 2008 43 49
14. S. Basu F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications Antioxid. Redox Signaling 10 2008 1405 1434
15. S. Basili, V. Raparelli, O. Riggio, M. Merli, R. Carnevale, F. Angelico, G. Tellan, P. Pignatelli, and F. Violi NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation Liver Int. 31 2011 1533 1540
16. G.L. Milne, H. Yin, K.D. Hardy, S.S. Davies, and L.J. Roberts 2nd Isoprostane generation and function Chem. Rev. 111 2011 5973 5996
17. U. Jahn, J.M. Galano, and T. Durand Beyond prostaglandins - chemistry and biology of cyclic oxygenated metabolites formed by free-radical pathways from polyunsaturated fatty acids Angew. Chem. Int. Ed. Engl. 47 2008 5894 5955
18. L.B. Ware, J.P. Fessel, A.K. May, and L.J. Roberts 2nd Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis Shock 36 2011 12 17
19. D.A. Barocas, S. Motley, M.S. Cookson, S.S. Chang, D.F. Penson, Q. Dai, G. Milne, L.J. Roberts 2nd, J. Morrow, R.S. Concepcion, J.A. Smith Jr., and J.H. Fowke Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer J. Urol. 185 2011 2102 2107
20. P. Montuschi, P.J. Barnes, and L.J. Roberts 2nd Isoprostanes: markers and mediators of oxidative stress FASEB J 18 2004 1791 1800
21. 2-isoprostanes stimulate collagen synthesis in activated hepatic stellate cells: a link with liver fibrosis? Lab. Invest. 85 2005 1381 1391
22. M. Comporti, C. Signorini, B. Arezzini, D. Vecchio, B. Monaco, and C. Gardi F2-isoprostanes are not just markers of oxidative stress Free Radic. Biol. Med. 44 2008 247 256
23. B.T. Kinsella Thromboxane A2 signalling in humans: a 'tail' of two receptors Biochem. Soc. Trans. 29 2001 641 654
24. S.J. Wilson, K. McGinley, A.J. Huang, and E.M. Smyth Heterodimerization of the α and β isoforms of the human thromboxane receptor enhances isoprostane signaling Biochem. Biophys. Res. Commun. 352 2007 397 403
25. C. Gardi, B. Arezzini, B. Monaco, M.G. De Montis, D. Vecchio, and M. Comporti F2-isoprostane receptors on hepatic stellate cells Lab. Invest. 88 2008 124 131
26. M. Sasaki, K. Miyosawa, S. Ohkubo, and N. Nakahata Physiological significance of thromboxane A(2) receptor dimerization J. Pharmacol. Sci. 100 2006 263 270
27. K. Miyosawa, M. Sasaki, S. Ohkubo, and N. Nakahata Different pathways for activation of extracellular signal-regulated kinase through thromboxane A2 receptor isoforms Biol. Pharm. Bull 29 2006 719 724
28. F.T. Khasawneh, J.S. Huang, F. Mir, S. Srinivasan, C. Tiruppathi, and G.C. Le Breton Characterization of isoprostane signaling: evidence for a unique coordination profile of 8-iso-PGF(2alpha) with the thromboxane A(2) receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets Biochem. Pharmacol 75 2008 2301 2315
29. N. Nakahata Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology Pharmacol. Ther. 118 2008 18 35
30. + current via cyclic AMP signaling pathway in murine renal artery Eur. J. Pharmacol 520 2005 22 28
31. T. Hirata, F. Ushikubi, A. Kakizuka, M. Okuma, and S. Narumiya Two thromboxane A2 receptor isoforms in human platelets: opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation J. Clin. Invest. 97 1996 949 956
32. F. Marra, W. Delogu, I. Petrai, S. Pastacaldi, A. Bonacchi, E. Efsen, S. Aleffi, C. Bertolani, M. Pinzani, and P. Gentilini Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells Am. J. Physiol. Gastrointest. Liver Physiol. 287 2004 18 26
33. G.L. Johnson, and R. Lapadat Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases Science 298 2002 1911 1912
34. J. Kluwe, J.P. Pradere, G.Y. Gwak, A. Mencin, S. De Minicis, C.H. Osterreicher, J. Colmenero, R. Bataller, and R.F. Schwabe Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition Gastroenterology 138 2010 347 359
35. T.A. Morinelli, L.M. Zhang, W.H. Newman, and K.E. Meier Thromboxane A2/prostaglandin H2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase J. Biol. Chem. 269 1994 5693 5698
36. M. Fukunaga, T. Yura, R. Grygorczyk, and K.F. Badr Evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2 Am. J. Physiol. 272 1997 477 483
37. M.D. Jiang, S.M. Zheng, H. Xu, W.Z. Zeng, Y. Zhang, H.P. Sun, Y.X. Wang, J.P. Qin, and X.L. Wu An experimental study of extracellular signal-regulated kinase and its interventional treatments in hepatic fibrosis Hepatobiliary Pancreatic Dis. Int 7 2008 51 57
38. P. De Bleser, A. Geerts, P. van Eyken, R. Vrijsen, J. Lazou, V. Desmet, and E. Wisse Tenascin synthesis in cultured rat liver fat-storing cell E. Wisse, D. Knook, R. McCusker, Cells of the Hepatic Sinusoid 1991 Kupffer Cell Foundation Rijswijk, The Netherlands 218 221
39. D. Boscoboinik, A. Szewczyk, C. Hensey, and A. Azzi Inhibition of cell proliferation by alpha-tocopherol: role of protein kinase C J. Biol. Chem. 266 1991 6188 6194
40. B. Peterkofsky, and R. Diegelmann Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins Biochemistry 10 1971 988 994
41. G. Poli Pathogenesis of liver fibrosis: role of oxidative stress Mol. Aspects. Med. 21 2000 49 98
42. S. Narumiya, and T. Furuyashiki Fever, inflammation, pain and beyond: prostanoid receptor research during these 25 years FASEB J 25 2011 813 818
43. R. Kostadinova, A. Montagner, E. Gouranton, S. Fleury, H. Guillou, D. Dombrowicz, P. Desreumaux, and W. Wahli GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation Cell. Biosci 2 2012 34 49
44. M. Comporti, B. Arezzini, C. Signorini, D. Vecchio, and C. Gardi Oxidative stress, isoprostanes and hepatic fibrosis Histol. Histopathol. 24 2009 893 900
45. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures, properties, and functions Physiol. Rev. 79 1999 1193 1226
46. Z.G. Goldsmith, and D.N. Dhanasekaran G protein regulation of MAPK networks Oncogene 26 2007 3122 3142
47. U.E. Lee, and S.L. Friedman Mechanisms of hepatic fibrogenesis Best Pract. Res. Clin. Gastroenterol 25 2011 195 206
48. C.J. Parsons, M. Takashima, and R.A. Rippe Molecular mechanisms of hepatic fibrogenesis J. Gastroenterol. Hepatol. 22 2007 S79 S84
49. S. Tsukada, J.K. Westwick, K. Ikejima, N. Sato, and R.A. Rippe SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cells J. Biol. Chem 280 2005 10055 10064
50. M. Fukunaga, T. Yura, K. Takahashi, and K.F. Badr Regulation of MAP-kinase activation by 8-iso-prostaglandin F2a in cultured rat aortic smooth muscle cells Adv. Exp. Med. Biol. 433 1997 193 196
51. S.M. Miggin, and B.T. Kinsella Thromboxane A(2) receptor mediated activation of the mitogen activated protein kinase cascades in human uterine smooth muscle cells Biochim. Biophys. Acta 1539 2001 147 162
52. H. Scholz, A. Yndestad, J.K. Damås, T. Waehre, S. Tonstad, P. Aukrust, and B. Halvorsen 8-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases Cardiovasc. Res. 59 2003 945 954
53. Y. Zhao, Y. Wang, Q. Wang, Z. Liu, Q. Liu, and X. Deng Hepatic stellate cells produce vascular endothelial growth factor via phospho-p44/42 mitogen-activated protein kinase/cyclooxygenase-2 pathway Mol. Cell. Biochem. 359 2012 217 223
54. Z. Lv, Y. Song, D. Xue, W. Zhang, Y. Cheng, and L. Xu Effect of salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells J. Ethnopharmacol. 132 2010 384 392
55. J. Tang, J. Chen, M. Ramanjaneya, A. Punn, A.C. Conner, and H.S. Randeva The signalling profile of recombinant human orexin-2 receptor Cell. Signalling 20 2008 1651 1661
56. V. Fortino, C. Torricelli, C. Gardi, G. Valacchi, S. Rossi Paccani, and E. Maioli ERKs are the point of divergence of PKA and PKC activation by PTHrP in human skin fibroblasts Cell. Mol. Life Sci. 59 2002 2165 2171
57. B.R. Sevetson, X. Kong, and J.C. Lawrence Increasing cAMP attenuates activation of mitogen-activated protein kinase Proc. Natl. Acad. Sci. USA 90 1993 10305 10309
58. J. Zhang, T.N. Bui, J. Xiang, and A. Lin Cyclic AMP inhibits p38 activation via CREB-induced dynein light chain Mol. Cell. Biol. 26 2006 1223 1234
59. A. Mallat, C. Gallois, J. Tao, A. Habib, J. Maclouf, P. Mavier, A.M. Préaux, and S. Lotersztajn Platelet-derived growth factor-BB and thrombin generate positive and negative signals for human hepatic stellate cell proliferation: role of a prostaglandin/cyclic AMP pathway and cross-talk with endothelin receptors J. Biol. Chem 273 1998 27300 27305
60. N. Ikeda, S. Murata, T. Maruyama, T. Tamura, R. Nozaki, T. Kawasaki, K. Fukunaga, T. Oda, R. Sasaki, M. Homma, and N. Ohkohchi Platelet-derived adenosine 5′-triphosphate suppresses activation of human hepatic stellate cell: in vitro study Hepatol. Res. 42 2012 91 102
61. P.J. Wermuth, S. Addya, and S.A. Jimenez Effect of protein kinase C delta (PKC-δ) inhibition on the transcriptome of normal and systemic sclerosis human dermal fibroblasts in vitro PLoS One 6 2011 e27110
62. H.N. Suh, S.H. Lee, M.Y. Lee, Y.J. Lee, J.H. Lee, and H.J. Han Role of interleukin-6 in the control of DNA synthesis of hepatocytes: involvement of PKC, p44/42 MAPKs, and PPARdelta Cell. Physiol. Biochem. 22 2008 673 684
63. T. Yura, M. Fukunaga, R. Khan, G.N. Nassar, K.F. Badr, and A. Montero Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells Kidney Int. 56 1999 471 478
64. N. Kawada, T.A. Tran-Thi, H. Klein, and K. Decker The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances: possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus Eur. J. Biochem 213 1993 815 823